Brigham and Women’s Hospital and Harvard Medical School, Boston, USA
An Associate Professor at the Brigham and Women’s Hospital and Harvard Medical School Boston, Daniel Chasman, Ph.D., is interested in genome-wide genetic analysis of cardiovascular traits and other related phenotypes. In particular, one component of his research emphasizes genetic approaches to understanding the clinical impact intermediate risk factors for CVD, including plasma lipid components, inflammatory biomarkers and blood pressure. The second component emphasizes the analysis of pharmacogenetic effects in aspirin and lipid-lowering therapies; and a third component investigates genetic susceptibility to migraine.
He also maintains an interest in genome-wide functional annotations to support purely statistical evidence for genetic association in interpretation of genetic signals. Previously, he was Director of Computational Biology and Statistical Genetics at Variagenics, a biotechnology company in Cambridge Massachusetts where he was engaged in exploring the potential for genetic testing for optimizing therapeutic strategies.